Spectrum Gets $16 Million From Asian Partners for Apaziquone Collaboration

Spectrum Pharmaceuticals, Inc. has announced that it has received $15 million from Nippon Kayaku in connection with the collaboration agreement for apaziquone (EOquin) announced on November 10, and $1 million from Handok Pharmaceuticals announced on November 23.
TradingMarkets